These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25454270)

  • 1. Histone deacetylase inhibitors derived from 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine and related heterocycles selective for the HDAC6 isoform.
    Blackburn C; Barrett C; Brunson M; Chin J; England D; Garcia K; Gigstad K; Gould A; Gutierrez J; Hoar K; Rowland RS; Tsu C; Ringeling J; Wager K; Xu H
    Bioorg Med Chem Lett; 2014 Dec; 24(23):5450-4. PubMed ID: 25454270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent histone deacetylase inhibitors derived from 4-(aminomethyl)-N-hydroxybenzamide with high selectivity for the HDAC6 isoform.
    Blackburn C; Barrett C; Chin J; Garcia K; Gigstad K; Gould A; Gutierrez J; Harrison S; Hoar K; Lynch C; Rowland RS; Tsu C; Ringeling J; Xu H
    J Med Chem; 2013 Sep; 56(18):7201-11. PubMed ID: 23964961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the discovery of potent and selective HDAC6 inhibitors.
    Wang XX; Wan RZ; Liu ZP
    Eur J Med Chem; 2018 Jan; 143():1406-1418. PubMed ID: 29133060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel HDAC6 isoform selective chiral small molecule histone deacetylase inhibitors.
    Smil DV; Manku S; Chantigny YA; Leit S; Wahhab A; Yan TP; Fournel M; Maroun C; Li Z; Lemieux AM; Nicolescu A; Rahil J; Lefebvre S; Panetta A; Besterman JM; Déziel R
    Bioorg Med Chem Lett; 2009 Feb; 19(3):688-92. PubMed ID: 19111466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyridylalanine-containing hydroxamic acids as selective HDAC6 inhibitors.
    Schäfer S; Saunders L; Schlimme S; Valkov V; Wagner JM; Kratz F; Sippl W; Verdin E; Jung M
    ChemMedChem; 2009 Feb; 4(2):283-90. PubMed ID: 19090524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of orally bioavailable aminopyrrolidinone histone deacetylase 6 inhibitors.
    Lin X; Chen W; Qiu Z; Guo L; Zhu W; Li W; Wang Z; Zhang W; Zhang Z; Rong Y; Zhang M; Yu L; Zhong S; Zhao R; Wu X; Wong JC; Tang G
    J Med Chem; 2015 Mar; 58(6):2809-20. PubMed ID: 25734520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent and selective HDAC6 inhibitory activity of N-(4-hydroxycarbamoylbenzyl)-1,2,4,9-tetrahydro-3-thia-9-azafluorenes as novel sulfur analogues of Tubastatin A.
    De Vreese R; Verhaeghe T; Desmet T; D'hooghe M
    Chem Commun (Camb); 2013 May; 49(36):3775-7. PubMed ID: 23538448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent and selective inhibition of histone deacetylase 6 (HDAC6) does not require a surface-binding motif.
    Wagner FF; Olson DE; Gale JP; Kaya T; Weïwer M; Aidoud N; Thomas M; Davoine EL; Lemercier BC; Zhang YL; Holson EB
    J Med Chem; 2013 Feb; 56(4):1772-6. PubMed ID: 23368884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural biasing elements for in-cell histone deacetylase paralog selectivity.
    Wong JC; Hong R; Schreiber SL
    J Am Chem Soc; 2003 May; 125(19):5586-7. PubMed ID: 12733869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs).
    Schäfer S; Saunders L; Eliseeva E; Velena A; Jung M; Schwienhorst A; Strasser A; Dickmanns A; Ficner R; Schlimme S; Sippl W; Verdin E; Jung M
    Bioorg Med Chem; 2008 Feb; 16(4):2011-33. PubMed ID: 18054239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel isoform-selective inhibitors within class I histone deacetylases.
    Hu E; Dul E; Sung CM; Chen Z; Kirkpatrick R; Zhang GF; Johanson K; Liu R; Lago A; Hofmann G; Macarron R; de los Frailes M; Perez P; Krawiec J; Winkler J; Jaye M
    J Pharmacol Exp Ther; 2003 Nov; 307(2):720-8. PubMed ID: 12975486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and bioactivity evaluation of ferrocene-based hydroxamic acids as selective histone deacetylase 6 inhibitors.
    Yan J; Yue K; Fan X; Xu X; Wang J; Qin M; Zhang Q; Hou X; Li X; Wang Y
    Eur J Med Chem; 2023 Jan; 246():115004. PubMed ID: 36516583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoform-Selective HDAC Inhibitor Therapy for Transplantation: Are We Ready for HDAC6?
    Hancock WW
    Transplantation; 2016 Aug; 100(8):1597-8. PubMed ID: 27222931
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors.
    Khan N; Jeffers M; Kumar S; Hackett C; Boldog F; Khramtsov N; Qian X; Mills E; Berghs SC; Carey N; Finn PW; Collins LS; Tumber A; Ritchie JW; Jensen PB; Lichenstein HS; Sehested M
    Biochem J; 2008 Jan; 409(2):581-9. PubMed ID: 17868033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of the first histone deacetylase 6/8 dual inhibitors.
    Olson DE; Wagner FF; Kaya T; Gale JP; Aidoud N; Davoine EL; Lazzaro F; Weïwer M; Zhang YL; Holson EB
    J Med Chem; 2013 Jun; 56(11):4816-20. PubMed ID: 23672185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of N-hydroxycinnamides capped with a naturally occurring moiety as inhibitors of histone deacetylase.
    Huang WJ; Chen CC; Chao SW; Lee SS; Hsu FL; Lu YL; Hung MF; Chang CI
    ChemMedChem; 2010 Apr; 5(4):598-607. PubMed ID: 20209563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Rational Approach for the Identification of Non-Hydroxamate HDAC6-Selective Inhibitors.
    Goracci L; Deschamps N; Randazzo GM; Petit C; Dos Santos Passos C; Carrupt PA; Simões-Pires C; Nurisso A
    Sci Rep; 2016 Jul; 6():29086. PubMed ID: 27404291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS.
    Simões-Pires CA; Zwick V; Cretton S; Cuendet M
    J Vis Exp; 2017 Aug; (126):. PubMed ID: 28829415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological activity of NCC149 derivatives as histone deacetylase 8-selective inhibitors.
    Suzuki T; Muto N; Bando M; Itoh Y; Masaki A; Ri M; Ota Y; Nakagawa H; Iida S; Shirahige K; Miyata N
    ChemMedChem; 2014 Mar; 9(3):657-64. PubMed ID: 24403121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The histone deacetylase-6 inhibitor tubacin directly inhibits de novo sphingolipid biosynthesis as an off-target effect.
    Siow D; Wattenberg B
    Biochem Biophys Res Commun; 2014 Jul; 449(3):268-71. PubMed ID: 24835950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.